Healthy volunteers help uncover drug interaction risks

NCT ID NCT05906836

First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 29 times

Summary

This study tested how a single dose of selpercatinib changes the amount of rosuvastatin in the blood of 28 healthy adults. The goal was to see if taking these two drugs together could lead to higher or lower levels of rosuvastatin, which might affect safety or effectiveness. Participants were monitored for about 26 days, and the results help doctors understand how to use these medications more safely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Labcorp Clinical Research LP

    Dallas, Texas, 75247, United States

Conditions

Explore the condition pages connected to this study.